181
Participants
Start Date
May 26, 2022
Primary Completion Date
June 2, 2023
Study Completion Date
June 2, 2023
Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
The drug was administered once every 4 weeks.
Peking University People's Hospital, Beijing
Baoji Central Hospital, Baoji
Beijing Hospital, Beijing
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Chenzhou First People's Hospital, Chenzhou
Pingxiang People's Hospital, Jiangxi
Jilin Province People's Hospital, Jilin
Affiliated Hospital of North Sichuan Medical College, Nanchong
Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing
Puyang Oilfield General Hospital, Pujiang
Qilu Hospital of Shandong University, Shandong
Peking University Shenzhen Hospital, Shenzhen
People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang
Zaozhuang Municipal Hospital, Zaozhuang
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Beijing VDJBio Co., LTD.
INDUSTRY